FENC Fennec Pharmaceuticals Inc. - Common Stock
$9,89
Cena · Maj 20, 2026
Dane fundamentalne na dzień Mar 27, 2026
Zakres 52 tyg.
$6–$10
92% of range
Ocena Analityków
BUY
13 analysts
Cena Docelowa
$15
+53% upside
P/E (TTM)
-22.6
ROE
-69.6%
Marża Zysku Netto
-21.8%
FENC Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$9.89
Kapitalizacja Rynkowa
$263M
P/E (TTM)
-22.6
EPS (TTM)
$-0.34
Przychody (TTM)
$45M
Stopa dywidendy
—
ROE
-69.6%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$6 – $10
FENC Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$45M
2017-12-31
→
2025-12-31
EPS
$-0.34
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
Marże
-21.8%
2023-12-31
→
2023-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
FENC
Mediana porównawcza
P/E (TTM)
-22.6
8.8
P/S (TTM)
5.9
50.9
P/B
7.4
2.9
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
FENC
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-14.1%
—
Net Profit Margin (Marża Zysku Netto)
-21.8%
-517.1%
ROA
-16.9%
-46.8%
ROE
-69.6%
-46.0%
ROIC
-17.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
FENC
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
6.4
8.3
Quick Ratio (Wskaźnik Szybkości)
3.5
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
FENC
Mediana porównawcza
Revenue YoY (Przychody R/R)
-6.1%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
207.5%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
204.7%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
FENC
Mediana porównawcza
FENC Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
13 analityków
- Mocne kupno 4 30,8%
- Kup 8 61,5%
- Trzymaj 1 7,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-05-14
Mediana
$15.50
← Poniżej wszystkich celów
$9.89
Niski
$13.00
Wysoki
$18.00
Średni cel
$15.50
+56,7%
Średnia cel
$15.17
+53,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.06%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $0.01 | $-0.01 | 0.02% |
| 31 grudnia 2025 | $-0.10 | $0.04 | -0.14% |
| 30 września 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 czerwca 2025 | $-0.11 | $-0.04 | -0.07% |
| 31 marca 2025 | $-0.04 | $-0.09 | 0.05% |
| 31 grudnia 2024 | $-0.06 | $0.17 | -0.23% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
| RCKT | — | — | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $48M | $21M | $2M | · | $200.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | $1M | $86.0K | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $20M | $1M | · | · | · | · | · | · | · | · | |
| R&D Expense | $250.0K | $307.0K | $56.0K | $4M | $5M | $5M | $6M | $5M | $2M | $472.0K | $256.0K | $357.0K | |
| SG&A Expense | $28M | $23M | $21M | $18M | $12M | $13M | $7M | $5M | $5M | $2M | $2M | $3M | |
| Operating Expenses | $51M | $45M | $34M | $24M | $17M | $18M | $13M | · | · | · | · | · | |
| Operating Income | $-6M | $3M | $-13M | $-23M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-2M | $-3M | |
| Interest Income | $787.0K | $2M | $441.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-3M | $-3M | $-3M | $-1M | $-123.0K | $-224.0K | $-17.0K | $6.0K | $-8.0K | $-14.0K | $-9.0K | $701.0K | |
| Pretax Income | $-10M | $-71.0K | $-16M | · | · | · | · | · | $-7M | $-3M | $-658.0K | $-2M | |
| Income Tax | $106.0K | $365.0K | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-10M | $-436.0K | $-16M | $-24M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-659.0K | $-2M | |
| EPS (Basic) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | · | · | · | · | $-0.06 | $-0.22 | |
| EPS (Diluted) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | · | · | · | · | $-0.06 | $-0.22 | |
| Shares (Basic) | 28,577,000 | 27,294,000 | 26,574,000 | 26,275,000 | 26,006,000 | 23,704 | 19,896,000 | 18,942,000 | 15,014,000 | 12,765,000 | 10,827,000 | 9,871,000 | |
| Shares (Diluted) | 28,577,000 | 27,294,000 | 26,574,000 | 26,275,000 | 26,006,000 | 23,704 | 19,896,000 | 18,942,000 | 15,014,000 | 12,765,000 | 10,827,000 | 9,871,000 | |
| EBITDA | $-6M | $3M | $-13M | $-23M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-2M | $-3M |
Bilans 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $27M | $13M | $24M | $21M | $30M | $14M | $23M | $28M | $4M | $942.0K | $2M | |
| Prepaid Expense | $4M | $3M | $3M | $770.0K | $1M | $797.0K | $226.0K | $168.0K | $128.0K | $43.0K | $76.0K | $48.0K | |
| Other Current Assets | $2M | $466.0K | $44.0K | $63.0K | $253.0K | $276.0K | $8.0K | $1.0K | $13.0K | $3.0K | $1.0K | $17.0K | |
| Current Assets | $67M | $44M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | · | · | · | |
| Other Non-current Assets | $717.0K | $822.0K | $816.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $71M | $45M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | $4M | $1M | $2M | |
| Accounts Payable | $5M | $3M | $4M | $2M | $777.0K | $2M | $2M | $1M | $855.0K | $244.0K | $297.0K | $308.0K | |
| Accrued Liabilities | $6M | $3M | $4M | $2M | $877.0K | $776.0K | $659.0K | $605.0K | $622.0K | $125.0K | $92.0K | $132.0K | |
| Current Liabilities | $11M | $7M | $8M | $5M | $2M | $2M | $2M | $2M | $2M | $402.0K | $471.0K | $2M | |
| Capital Leases | · | · | $2.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $35M | $51M | $38M | $30M | $7M | $2M | $2M | $2M | $2M | $402.0K | $471.0K | $2M | |
| Long-term Debt | · | $19M | $31M | $25M | · | · | · | · | · | · | · | · | |
| Common Stock | $190M | $146M | $144M | $143M | $141M | $141M | $106M | $106M | $103M | $75M | $69M | $69M | |
| Retained Earnings | $-229M | $-220M | $-219M | $-203M | $-179M | $-162M | $-144M | $-131M | $-121M | $-114M | $-112M | $-111M | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $35M | $-6M | $-12M | $-3M | $16M | $29M | $12M | $21M | $27M | $4M | $548.0K | $613.0K | |
| Liabilities + Equity | $71M | $45M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | $4M | $1M | $2M | |
| Shares Outstanding | 34,163,000 | 27,527,000 | 27,027,000 | 26,361,000 | 26,014,000 | 26,003,000 | 19,896,000 | 19,896,000 | 18,411,000 | 13,643,000 | 10,940,000 | 10,593,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $2M | $615.0K | $97.0K | $627.0K | |
| Operating Cash Flow | $-12M | $27M | $-17M | $-18M | $-14M | $-16M | $-9M | $-8M | $-4M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Debt Issued | · | · | $5M | $25M | $5M | · | · | · | · | · | · | · | |
| Net Debt Issued | $-19M | $-13M | $5M | $25M | $5M | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | $32M | $0 | $0 | $27M | $5M | $0 | $2M | |
| Net Stock Activity | · | · | · | · | · | $32M | · | $0 | $27M | $5M | $0 | $2M | |
| Financing Cash Flow | $23M | $-14M | $7M | $21M | $5M | $32M | $-71.0K | $2M | $28M | $5M | · | $2M | |
| Net Change in Cash | $10M | $13M | $-11M | $3M | $-9M | $17M | $-9M | $-5M | $24M | $3M | $-1M | $644.0K | |
| Taxes Paid | $748.0K | · | · | · | · | · | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.1% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -14.1% | 5.4% | -60.1% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -21.8% | -0.92% | -75.5% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -21.6% | -0.15% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -14.1% | 5.4% | -60.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -16.9% | -1.2% | -68.5% | -96.1% | -64.5% | -79.5% | -68.9% | -38.5% | -43.5% | -111.8% | -38.9% | -105.5% | |
| ROE | -69.6% | 7.9% | 144.9% | -20355.4% | -99.7% | -60.1% | -95.1% | -44.8% | -38.7% | -71.6% | -84.1% | 107.6% | |
| ROIC | -17.9% | -268.6% | · | · | · | · | · | · | -26.0% | -80.4% | · | -469.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 6.4 | 3.6 | 5.8 | 13.5 | 13.4 | 6.1 | · | · | · | · | · | |
| Quick Ratio | 3.5 | 3.8 | 1.8 | 5.2 | 12.8 | 12.9 | 6.0 | 13.9 | 17.2 | 9.8 | 2.0 | 1.3 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.3 | 0.9 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -6.1% | 123.7% | 1284.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 207.5% | · | 400.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 204.7% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $48M | $21M | $2M | $0 | $200.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-10M | $-436.0K | $-16M | $-24M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-659.0K | $-2M | |
| Market Cap | $263M | $174M | $303M | $253M | $114M | $194M | $129M | $127M | $184M | · | · | · | |
| P/E | -22.6 | -316.0 | -18.7 | -10.7 | -6.6 | -9.8 | -19.7 | -12.3 | -27.8 | · | · | · | |
| P/S | 5.9 | 3.7 | 14.3 | 164.9 | · | 968.6 | · | · | · | · | · | · | |
| P/B | 7.4 | -29.6 | -26.1 | -98.5 | 7.3 | 6.7 | 10.9 | 6.0 | 6.9 | · | · | · | |
| P / Tangible Book | 7.4 | · | · | · | 7.3 | 6.7 | · | · | · | · | · | · | |
| P / Cash Flow | -21.1 | 6.4 | -17.7 | -14.0 | -8.0 | -12.4 | -14.3 | -16.2 | -50.7 | · | · | · | |
| Earnings Yield | -4.4% | -0.32% | -5.3% | -9.4% | -15.2% | -10.2% | -5.1% | -8.2% | -3.6% | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $12M | $10M | $9M | $8M | $7M | $7M | $25M | $10M | $7M | $3M | $2M | · | · | · | · | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $331.0K | $148.0K | $95.0K | · | · | · | · | |
| Gross Profit | · | · | · | · | · | · | · | · | · | $6M | $3M | $2M | · | · | · | · | |
| R&D Expense | $20.0K | $29.0K | $107.0K | $94.0K | $50.0K | $97.0K | $157.0K | $3.0K | $32.0K | $12.0K | $8.0K | $4.0K | $117.0K | $846.0K | $1M | $1M | |
| SG&A Expense | $8M | $7M | $7M | $6M | $4M | $6M | $7M | $6M | $7M | $4M | $5M | $4M | $5M | $7M | $4M | $2M | |
| Operating Expenses | $16M | $13M | $12M | $10M | $9M | $12M | $12M | $12M | $12M | $8M | $8M | $7M | $18M | $8M | $-5M | $4M | |
| Operating Income | $-3M | $-189.0K | $-3M | $-808.0K | $-934.0K | $-5M | $-5M | $14M | $-2M | $-1M | $-5M | $-5M | $-6M | $-8M | $-5M | $-4M | |
| Interest Income | $228.0K | $152.0K | $171.0K | $236.0K | $399.0K | $516.0K | $570.0K | $197.0K | $115.0K | $102.0K | · | · | · | · | · | · | |
| Other Non-op | $-2M | $-449.0K | $-420.0K | $-357.0K | $-686.0K | $-533.0K | $-514.0K | $-906.0K | $-864.0K | $-850.0K | $-778.0K | $-782.0K | $-722.0K | $-190.0K | $-63.0K | $-150.0K | |
| Net Income | $-5M | $-638.0K | $-3M | $-1M | $-2M | $-6M | $-6M | $13M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | $-5M | $-4M | |
| EPS (Basic) | $-0.17 | $-0.02 | $-0.11 | $-0.04 | $-0.08 | $-0.21 | $-0.20 | $0.47 | $-0.09 | $-0.07 | $-0.21 | $-0.23 | $-0.26 | $-0.31 | $-0.19 | $-0.14 | |
| EPS (Diluted) | $-0.17 | $-0.02 | $-0.11 | $-0.04 | $-0.02 | $-0.21 | $-0.20 | $0.41 | $-0.09 | $-0.07 | $-0.21 | $-0.23 | $-0.26 | $-0.31 | $-0.19 | $-0.14 | |
| Shares (Basic) | -54,554,000 | 27,889,000 | 27,664,000 | 27,578,000 | -54,419,000 | 27,371,000 | 27,297,000 | 27,045,000 | -53,039,000 | 26,596,000 | 26,458,000 | 26,559,000 | -51,904,000 | 26,108,000 | 26,052,000 | 26,019,000 | |
| Shares (Diluted) | -54,554,000 | 27,889,000 | 27,664,000 | 27,578,000 | -58,465,000 | 27,371,000 | 27,297,000 | 31,091,000 | -53,039,000 | 26,596,000 | 26,458,000 | 26,559,000 | -51,904,000 | 26,108,000 | 26,052,000 | 26,019,000 | |
| EBITDA | · | $-189.0K | $-3M | $-808.0K | · | $-5M | $-5M | $14M | · | $-1M | $-5M | $-5M | · | $-8M | $-5M | $-4M |
Bilans 19
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $22M | $19M | $23M | $27M | $40M | $43M | $51M | $13M | $12M | $15M | $18M | $24M | $30M | $15M | $18M | |
| Prepaid Expense | $4M | $1M | $1M | $2M | $3M | $3M | $4M | $4M | $3M | $247.0K | $457.0K | $639.0K | $770.0K | $278.0K | $490.0K | $715.0K | |
| Other Current Assets | $2M | $898.0K | $965.0K | $1M | $466.0K | $546.0K | $283.0K | $161.0K | $44.0K | $20.0K | $32.0K | $32.0K | $63.0K | $123.0K | $149.0K | $154.0K | |
| Current Assets | $67M | $46M | $41M | $43M | $44M | $58M | $62M | $68M | $27M | $19M | $19M | $22M | $27M | $30M | $16M | $19M | |
| Other Non-current Assets | $717.0K | $743.0K | $768.0K | $794.0K | $822.0K | $956.0K | $989.0K | $1M | $816.0K | · | · | · | · | · | · | · | |
| Total Assets | $71M | $49M | $45M | $46M | $45M | $59M | $63M | $69M | $27M | $19M | $19M | $22M | $27M | $30M | $16M | $19M | |
| Accounts Payable | $5M | $6M | $6M | $5M | $3M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $6M | $4M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $951.0K | $773.0K | $1M | $2M | $394.0K | $294.0K | $412.0K | |
| Current Liabilities | $11M | $10M | $8M | $8M | $7M | $7M | $8M | $10M | $8M | $4M | $4M | $4M | $5M | $3M | $3M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | $7.0K | · | · | · | · | · | · | |
| Total Liabilities | $35M | $54M | $52M | $52M | $51M | $64M | $65M | $66M | $38M | $30M | $29M | $29M | $30M | $28M | $7M | $7M | |
| Long-term Debt | · | $19M | $19M | $19M | · | $32M | $32M | $31M | · | $26M | $25M | $25M | · | $25M | $5M | $5M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $5M | $5M | |
| Common Stock | $190M | $148M | $146M | $146M | $146M | $145M | $145M | $145M | $144M | $144M | $143M | $143M | $143M | $141M | $141M | $141M | |
| Retained Earnings | $-229M | $-225M | $-224M | $-221M | $-220M | $-218M | $-212M | $-206M | $-219M | $-217M | $-215M | $-209M | $-203M | $-196M | $-188M | $-183M | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $35M | $-4M | $-7M | $-6M | $-6M | $-5M | $-1M | $3M | $-12M | $-11M | $-10M | $-7M | $-3M | $3M | $9M | $13M | |
| Liabilities + Equity | $71M | $49M | $45M | $46M | $45M | $59M | $63M | $69M | $27M | $19M | $19M | $22M | $27M | $30M | $16M | $19M | |
| Shares Outstanding | 34,163,000 | 28,062,000 | 27,733,000 | 27,594,000 | 27,527,000 | 27,422,000 | 27,329,000 | 27,105,000 | 27,027,000 | 26,635,000 | 26,509,000 | 26,411,000 | 26,361,000 | 26,238,000 | 26,067,000 | 26,040,000 |
Przepływy pieniężne 5
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $1M | $798.0K | $1M | $2M | $925.0K | $1M | $857.0K | $865.0K | $3M | $1M | $827.0K | $2M | $1M | $399.0K | |
| Operating Cash Flow | $-6M | $1M | $-4M | $-4M | $-1M | $-2M | $-8M | $39M | $-5M | $-3M | $-4M | $-6M | $-7M | $-5M | $-3M | $-3M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $-65.0K | · | · | · | |
| Financing Cash Flow | $21M | $2M | $-284.0K | $359.0K | $-12M | $-528.0K | $257.0K | $-1M | $6M | $201.0K | $514.0K | $193.0K | $824.0K | $20M | $46.0K | $15.0K | |
| Net Change in Cash | $15M | $3M | $-4M | $-4M | $-14M | $-3M | $-8M | $38M | $870.0K | $-3M | $-3M | $-5M | $-6M | $15M | $-3M | $-3M |
Rentowność 6
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | 94.9% | · | · | · | · | · | · | |
| Operating Margin | · | -1.5% | -28.3% | -9.2% | · | -74.6% | -69.4% | 54.2% | · | -15.6% | · | · | · | · | · | · | |
| Net Margin | · | -5.1% | -32.7% | -13.3% | · | -82.2% | -76.5% | 50.6% | · | -28.7% | · | · | · | · | · | · | |
| EBITDA Margin | · | -1.5% | -28.3% | -9.2% | · | -74.6% | -69.4% | 54.2% | · | -15.6% | · | · | · | · | · | · | |
| ROA | · | -1.2% | -5.8% | -2.0% | · | -14.7% | -13.5% | 28.2% | · | -7.5% | -31.1% | -29.5% | · | -28.7% | -23.2% | -15.7% | |
| ROE | · | 13.2% | 71.5% | 81.3% | · | 73.0% | 100.2% | -593.6% | · | 48.3% | 918.0% | -233.4% | · | -74.2% | -32.9% | -19.7% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.7 | 4.8 | 5.1 | · | 7.8 | 8.0 | 6.9 | · | 4.8 | 5.1 | 5.4 | · | 10.3 | 5.1 | 9.0 | |
| Quick Ratio | · | 2.2 | 2.2 | 2.7 | · | 5.4 | 5.6 | 5.2 | · | 3.2 | 4.0 | 4.6 | · | 10.2 | 4.9 | 8.5 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.9 | 0.6 | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.9 | 0.5 | 0.4 |
Efektywność 1
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.6 | · | 0.3 | · | · | · | · | · | · |
Wycena (TTM) 11
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $38M | $33M | $48M | · | $46M | $42M | $37M | · | · | · | · | · | $0 | $0 | $0 | |
| Net Income TTM | · | $-11M | $-16M | $384.0K | · | $-318.0K | $-27.0K | $-526.0K | · | $-21M | $-25M | $-23M | · | $-21M | $-17M | $-17M | |
| Market Cap | · | $263M | $230M | $168M | · | $137M | $167M | $301M | · | $200M | $234M | $220M | · | $213M | $145M | $146M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $208M | $136M | $133M | |
| P/E | · | -24.6 | -14.8 | -152.2 | · | -71.4 | -87.3 | -111.2 | · | -9.2 | -9.4 | -9.6 | · | -10.1 | -8.7 | -8.9 | |
| P/S | · | 6.9 | 7.1 | 3.5 | · | 3.0 | 3.9 | 8.2 | · | · | · | · | · | · | · | · | |
| P/B | · | -58.5 | -30.8 | -28.6 | · | -26.5 | -123.1 | 100.0 | · | -19.0 | -24.1 | -29.9 | · | 75.8 | 17.0 | 11.6 | |
| P / Tangible Book | · | · | · | · | · | · | · | 100.0 | · | · | · | · | · | 75.8 | 17.0 | 11.6 | |
| P / Cash Flow | · | · | · | -38.9 | · | · | · | 7.7 | · | · | · | -39.4 | · | · | -42.9 | -51.1 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | -26.3 | -27.1 | -37.4 | |
| Earnings Yield | · | -4.1% | -6.8% | -0.66% | · | -1.4% | -1.1% | -0.90% | · | -10.9% | -10.7% | -10.5% | · | -9.9% | -11.5% | -11.2% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Przychody | $45M | $48M | $21M | — | $2M |
| Marża Brutto % | — | — | 94.1% | — | — |
| Marża Operacyjna % | -14.1% | 5.4% | -60.1% | — | — |
| Zysk netto | $-10M | $-436.0K | $-16M | — | $-24M |
| Rozwodniony EPS | $-0.34 | $-0.02 | $-0.60 | — | $-0.90 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.4 | 6.4 | 3.6 | — | 5.8 |
| Wskaźnik Szybkości | 3.5 | 3.8 | 1.8 | — | 5.2 |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.